MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis	https://doi.org/10.18632/aging.102325	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-1 Suppresses Proliferation of Osteosarcoma Cells by Up-regulating p21 via PAX3	https://doi.org/10.21873/cgp.20113	2019	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-22 promotes apoptosis of osteosarcoma cells via inducing cell cycle arrest	https://doi.org/10.3892/ol.2017.5674	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Inhibition of miR-9 decreases osteosarcoma cell proliferation	https://doi.org/10.17305/bjbms.2019.4434	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-497 suppresses osteosarcoma tumor growth in vitro and in vivo	https://doi.org/10.3892/ol.2016.4162	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-874-mediated inhibition of the major G(1)/S phase cyclin, CCNE1, is lost in osteosarcomas	https://doi.org/10.1074/jbc.M117.808287	2017	Cell line 4 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-497 suppress osteosarcoma by targeting MAPK/Erk pathway	https://doi.org/10.4149/BLL_2017_087	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis	https://doi.org/10.1016/j.bbrc.2017.11.121	2018	Cell line 4 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells	https://doi.org/10.1158/1535-7163.MCT-12-0869	2013	Cell line 8 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-23a enhances migration and invasion through PTEN in osteosarcoma	https://doi.org/10.1038/cgt.2015.27	2015	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-199a-3p and microRNA-34a regulate apoptosis in human osteosarcoma cells	https://doi.org/10.1042/BSR20140084	2014	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication	https://doi.org/10.1371/journal.pone.0166027	2016	Cell line 8 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication	https://doi.org/10.1371/journal.pone.0166027-	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells	https://doi.org/10.1371/journal.pone.0161023	2016	Cell line 5 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
HOTAIR promotes osteosarcoma development by sponging miR-217 and targeting ZEB1	https://doi.org/10.1002/jcp.27394	2019	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-155 targets MAP3K10 and regulates osteosarcoma cell growth	https://doi.org/10.1016/j.prp.2016.12.028	2017	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-506-3p initiates mesenchymal-to-epithelial transition and suppresses autophagy in osteosarcoma cells by directly targeting SPHK1	https://doi.org/10.1080/09168451.2019.1569496	2019	Cell line 5 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
FOXO1-MALAT1-miR-26a-5p Feedback Loop Mediates Proliferation and Migration in Osteosarcoma Cells	https://doi.org/10.3727/096504017X14859934460780	2017	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
CTGF promotes osteosarcoma angiogenesis by regulating miR-543/angiopoietin 2 signaling	https://doi.org/10.1016/j.canlet.2017.01.013	2017	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
microRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6	https://doi.org/10.1007/s13277-014-3034-2	2015	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications